A B S T R A C T Previous reports have described conflicting results concerning the glycoprotein (GP) and protein composition of Bernard-Soulier platelets. In view of this controversy we have analyzed the platelets of four Bernard-Soulier patients using improved single and two-dimensional sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis procedures. An absence of staining for carbohydrate of membrane GP lb was characteristic for the platelets of each patient. Major periodate-Schiff staining bands corresponding to membrane GP lIb, Illa, and IlIb were clearly detected and their presence was confirmed by two-dimensional SDS-polyacrylamide gel electrophoresis. The protein content of the Bernard-Soulier platelets was increased two-to fourfold. However, analysis of their protein composition using 7-12% acrylamide gradient gels showed normal polypeptide profiles. Lactoperoxidase-catalyzed 125I-labeling of the Bernard-Soulier platelet surface proteins was followed by SDS-polyacrylamide gel electrophoresis and autoradiography. No labeling in the Ib position was detected whereas the other major membrane GP, including Ia and Ila, were normally located. In contrast, GP lb was clearly detected by periodate-Schiff staining and autoradiography when normal human platelets that had been exhaustively treated with neuraminidase before the lactoperoxidase-catalyzed iodination were analysed. No abnormalities were detected in the GP patterns of membranes isolated from the patients' erythrocytes. Only a severe molecular abnormality or possible deletion of GP lb could account for this major platelet lesion in the Bernard-Soulier syndrome.
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INTRODUCTION
The Bernard-Soulier (B-S)l syndrome is a congenital platelet disorder with an autosomal recessive inheritance that was originally characterised by the association of a prolonged bleeding time, the presence of abnormally large platelets on peripheral blood smears, an often observed thrombocytopenia, and a defective prothrombin consumption test (1) . Subsequent studies have suggested that the bleeding tendency arises from an abnormality in the platelet-vessel wall interaction, or more specifically, in a diminished platelet ability to adhere to subendothelium (2) (3) (4) . B-S platelets are not agglutinated by bovine factor VIII (5, 6) or by ristocetin in the presence of normal human plasma (7, 8) . A diminished binding of certain coagulation factors to B-S platelets has been noted (6) whereas a reduced binding of 125I-labeled thrombin to B-S platelets was correlated with a decreased aggregation response specifically observed with this stimulus (9, 10) . Finally, B-S platelets have been shown to lack the receptor for quinine-or quinidine-dependent antibodies (11) .
Grottum and Solum (12) first reported that the platelets of two B-S patients had a reduced sialic acid content and electrophoretic mobility. This observation suggested the presence of a membrane glycoprotein abnormality. Nurden and Caen (13) subsequently located a severe reduction in the periodate-Schiff (PAS)-staining intensity of the then-termed glycoprotein (GP) I band following the analysis by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) of membranes isolated from the platelets of two B-S patients. This abnormality was confirmed by the direct analysis of unfractionated B-S platelets by SDS-PAGE (3). In contrast, Jenkins et al. (14) reported other findings after their studies on the platelets of a different B-S patient. These authors detected a diffuse PAS band in the GP I position after SDS-PAGE and were unable to detect PAS-staining in the GP II and III positions. Furthermore, widespread changes in both the platelet protein composition and the 125I-labeling pattern of the surface-orientated polypeptides were observed and emphasized. In recently published studies, Hagen et al. (15) , and Shulman and Karpatkin (16) analyzed B-S platelets by crossed immunoelectrophoresis using rabbit antisera raised against normal human platelets (15) or isolated platelet membranes (16) . Markedly different findings were reported. Hagen et al. (15) located a specific defect involving GP Ib and glycocalicin, a high molecular weight glycopeptide reported to be released from Ib as a result of Ca2+-dependent protease activity (17) . In contrast, Shulman and Karpatkin (16) noted numerous differences and suggested that the abnormalities observed in the B-S syndrome and those ofa second hereditary platelet disorder, Glanzmann's thrombasthenia, reflected differences in endogenous membrane proteolysis.
In view of the apparent contradiction between our initial observations and those of Jenkins et al. (14) , the increased complexity of the human platelet membrane GP composition as revealed by the introduction of improved SDS-PAGE procedures, and the lack of agreement in the reports on the analysis of B-S platelets by crossed immunoelectrophoresis, we now describe further studies performed on the platelets of four B-S patients. Analysis ofthe GP and proteins of 125I-labeled platelets of each patient by refined single and two-dimensional SDS-PAGE procedures has established that B-S platelets possess a specific and characteristic membrane GP lesion. Furthermore, a comparison with the results obtained for control platelets labeled with 125I after treatment with neuraminidase to remove exposed sialic acid residues has shown that a decreased sialic acid content cannot alone account for the observed B-S platelet surface alterations.
METHODS

Materials
Dextran T 500 was obtained from Pharmacia Fine Chemicals, Uppsala, Sweden and sodium metrizoate solution (32.8% wt/vol, density 1.20 (21) . The erythrocytes were progressively clumped by the dextran and sedimented. The PRP was removed and the platelet and leukocyte content enumerated by phase contrast microscopy. The PRP was then centrifuged at 250 g for 5 min and the platelet and leukocyte content of the suspension re-evaluated. The sedimented cells were discarded. This process was repeated until the leukocyte contamination was <1% platelets (normally one or two centrifugations were sufficient).
The platelets in the PRP were finally sedimented by centrifugation at 3,000 g for 15 min and resuspended in small volumes (10 ml buffer for the platelets sedimented from 50 ml PRP) of 0.01 M Tris-HCl, pH 7.4, containing 0.15 M NaCl, 5 mM glucose, and 1 mM EDTA. The concentrated platelet suspension was centrifuged at 2,600 g for 15 min in transparent plastic conical tubes (12 ml capacity). Any remaining erythrocytes settled to the base of the cone; the overlying platelets in the pellet were carefully resuspended and washed twice with half the original PRP volume of the above buffer.
Lactoperoxidase-catalyzed iodination
Washed control platelets were resuspended at 1 x 109 platelets/ml in 0.01 M Tris-HCl, pH 7.4, containing 0.15 M NaCl and 1 mM EDTA. The platelets of the B-S patients were likewise resuspended but at 5 x 108 platelets/ml. The protocol used for lactoperoxidase-catalyzed 1251-labeling was based on the method of Phillips and Poh Agin (22 
SDS-PAGE procedures
Washed unlabeled or 125I-labeled control platelets were resuspended at 2 x 109 platelets/ml in 0.01 M Tris-HCl, pH 7.0, containing 0.15 M NaCl, 3 mM EDTA and 5 mM N-ethylmaleimide. B-S platelets were similarly resuspended, but at a concentration of 5 x 108 platelets/ml. A one-fifth volume of 12% SDS was added and the samples heated at 100°C for 5 min. After cooling, aliquots were taken for protein analysis (23) and the rest was frozen at -20°C. Disulfide bond reduction was perforned immediately before electrophoresis by incubating the samples at 37°C for 1 h in the presence of 5% vol/vol 2-mercaptoethanol.
GP analysis. SDS-PAGE was performed using 10.5 x 0.5-cm polyacrylamide rod gels and the Laemmli (24) buffer systems. Each sample contained 400 ,ug platelet protein and was mixed with 20 gl 50% vol/vol glycerol containing 0.0025% wt/ vol bromophenol blue tracking dye before being applied to the gel. An internal standard for the PAS reaction, 5 ,ug orosomucoid dissolved in 2% SDS, was added to the sample before electrophoresis and before reduction. Reduced samples were analyzed on 6% acrylamide (0.2% bis) separating gels, nonreduced samples on 7% acrylamide (0.2% bis) separating gels. Each gel was overlayered with a 1.0 cm 3.5% acrylamide stacking gel. Electrophoresis was performed overnight at 25 V and continued until the tracking dye approached within 0.5 cm of the base of the tube. After electrophoresis the gels were washed overnight in 25% vol/vol isopropanol: 10% vol/vol acetic acid. GP were located by the PAS reaction (25) ; the Schiff reagent was prepared fresh each month according to the procedure of Segrest and Jackson (26) . The stained gels were stored at 4°C in 7% acetic acid and densitometrically scanned within 24 h using a Vernon Recording Photometer (Vernon Integrating Photometers, Paris, France) equipped with a green (Wratten No. 7) filter.
Polypeptide analysis. Samples were prepared and disulfide bonds reduced exactly as described for the GP analysis. SDS-PAGE was performed using 7.0-12.0% exponential gradient acrylamide slab gels of dimensions 10 (height) x 14 (length) x 0.15 cm (thickness). The ratio (g:g) of bis to acrylamide was maintained at 0.027 throughout the gradient. A 1-cm 3.0% acrylamide stacking gel was also used. The buffer systems of Laemmli (24) were again used and electrophoresis performed overnight at 25 V in a Bio-Rad model 220 vertical slab electrophoresis cell. Samples containing 100 ,ug protein were analyzed. Polypeptides were located using Coomassie Blue R 250 (27) . Stained gels were incubated for 1 h in 10% vol/ vol acetic acid containing 1% vol/vol glycerol and dried onto filter paper using a Bio-Rad model 224 Gel Slab Dryer. 125I. labeled polypeptides were located by autoradiography, the dried gels being left in contact with Kodak X-Omat MA film at room temperature for up to 2 wk, after which the films were processed according to the manufacturer's instructions.
Two-dimensional SDS-PAGE analysis. This was performed using an adaptation of the nonreduced/reduced two dimensional system of SDS-PAGE analysis as applied to platelets by Phillips and Poh Agin (22) . First dimension SDS-PAGE was performed using 7% acrylamide (0.2% bis) tube gels and nonreduced samples as outlined in the GP analysis section, 100 ,g SDS-solubilized platelet protein now being applied to the gel. After electrophoresis the unstained gels were agitated for 1 h at room temperature in the presence of 0.01 M Tris, pH 7.0, containing 3 mM EDTA and 5% vol/vol 2-mercaptoethanol. The second dimension electrophoresis was performed using 7-12% exponential gradient acrylamide slab gels as outlined in the section polypeptide analysis. One exception was the substitution ofthe outer standard glass plate in the gel forming apparatus with a plate with a bevelled upper edge (Bio-Rad Laboratories). The gel containing the now-reduced polypeptides was layered onto the second dimension gel, over the 3% stacking gel. The rod gel was fixed in position by the addition of a small volume of 1% agarose dissolved by warming in 10 mM Tris, pH 7.0. A small plastic template was attached at the right-hand side of the layered polyacrylamide tube gel before addition of the agarose. An aliquot (100 fi.g protein) of reduced proteins ofthe sample being analyzed was added to the cavity in the agarose that formed when the template was removed. After electrophoresis the gels were stained with Coomassie Blue R 250. On occasion, PAS-staining was first performed to locate the position ofthe major GP. The detection of '25I-labeled proteins by autoradiography was performed as described in the section polypeptide analysis.
Molecular weight determinations. Apparent molecular weights ofthe platelet GP and polypeptides were determined by comparing their relative migration during SDS-PAGE with that of the following standard proteins: myosin heavy chain (200,000 mol wt), f3-galactosidase (116,500 mol wt), phosphorylase b (94,000 mol wt), bovine serum albumin (68,000 mol wt), ovalbumin (43,000 mol wt), carbonic anhydrase (30,000 mol wt), soybean trypsin inhibitor (21,000 mol wt) and lysozyme (14,300 mol wt). Mixtures containing 2.5 ,ug of each protein were incubated with SDS and 2-mercaptoethanol and SDS-PAGE performed exactly as described for the platelet samples. Measurements were made to the leading edge of the stained bands.
Neuraminidase digestion
Washed normal human platelet suspensions were resuspended at 1 x 109 platelets/ml in 0.01 M sodium phosphate, pH 7.4, containing 0.15 M NaCl. Preincubation at 37°C for 2 min was followed by the addition of 0.05 vol neuraminidase (500 U/ml) in 0.05 M sodium acetate buffer, pH 5.5, containing 0.154 M NaCl and 0.009 M CaCl2. The incubation was continued with agitation for 15 min, at which time the digestion was stopped by the addition of 4 mM EDTA. The platelets were sedimented and washed once in 0.01 M Tris-HCl, pH 7.4, containing 0.15 M NaCl and 1 mM EDTA and then resuspended for lactoperoxidase-catalyzed (1251) iodination. Total platelet sialic acid was estimated by the thiobarbituric acid method of Aminoff (28) following its release by hydrolysis with 0.1 N H2SO4 at 80°C for 1 h. Neuraminidase-released sialic acid was measured without prior acid hydrolysis. Optical densities were read at both 532 and 549 nm and adjusted for the presence of 532-nm-absorbing impurities (29) . RESULTS B-S platelets. As is characteristic for the B-S syndrome each of the patients possessed a low circulating platelet count at the time of study (Table I ). The protein content of the isolated platelets was increased, ranging from two to four times the normal amounts. Approximately 30% less sialic acid/mg protein was located in the platelets of the two patients where it was estimated.
Platelet GP nomenclature. The four major PASstaining membrane GP are termed Ib, IIb, IIIa, and Illb according to the criteria described by Nurden and Caen (30) to the intracellular, granule localized GP that has been termed "thrombin sensitive protein" (31) or "thrombospondin" (32) . Other membrane GP are given the nomenclature established by Phillips and Poh Agin (22) where it was clearly apparent that their electrophoretic mobilities, with and without disulfide bond reduction, were comparable. Platelet GP analysis. Preliminary studies established that the optimal separation of the major PASstaining platelet GP was achieved using the Laemmli (24) system of electrophoresis. Rod gels were used to facilitate densitometric scanning. The optimal acrylamide concentration for the analysis of reduced samples was found to be 6% acrylamide (0.2% bis). Fig. 1 compares the GP profiles of reduced samples of normal human platelets and those of the B-S patient (R.B.). The B-S platelet profile shows a specific and severe reduction in the PAS-staining intensity of the lb band. Note that the absence of this band allows the full appearance of a PAS-peak, band 4, present as a slowly migrating shoulder to GP lb in the normal platelet profile. Band 4 has an apparent molecular weight of 160,000 and for reasons referred to later probably represents the PAS stain of GP Ia and IIa.
As detailed by Phillips and Poh Agin (22) , the platelet membrane GP contain differing amounts of interor intramolecular disulfide bonds, thus their rate of migration during electrophoresis depends on the state of reduction of these bonds. Fig. 2 ethylmaleimide before heating samples at 1000C with SDS to prevent formation of high molecular weight aggregates of both membrane proteins and GP that fail to penetrate the separating gel. A similar observation has previously been made (22) . Platelet protein composition. Analysis of the B-S platelet proteins was performed on 7-12% gradient acrylamide slab gels allowing the detection ofthe major polypeptides within a molecular weight range of 400,000 to 20,000. The polypeptide profiles ofthe platelets of two patients are illustrated in Fig. 3 . No gross protein abnormalities were observed. In particular, three large polypeptides with apparent molecular weights of 250,000, 230,000, and 200,000 were normally detected. These polypeptides, which have been shown to be highly sensitive to degradation by an endogenous platelet calcium-sensitive protease (33) , have been reported to be modified in B-S platelets (14) . As shown in Table I , the total protein content of B-S platelets was increased relative to nonnal human platelets. Fig. 3 shows that this increase, whether it was two-(W.B.) or fourfold (N.V.) was the result ofa general augmentation of the platelet proteins. We saw no sign of plasma protein absorption. The position of GP lb was located by prior PAS-staining and is shown in Fig. 3 . A faint Coomassie Blue band normally observed in this position was missing from the B-S platelet polypeptide pattern. In contrast, the Coomassie Blue band given by GP Ilb, which is only separated from other comigrating polypeptides on nonreduced gels (22) , was present and possessed a normal migration.
Analysis of 1251-labeled platelets. The surface proteins of platelets isolated from patients (N.V., R.B., and W.B.) have been labeled with 125I by the lactoperoxidase-catalyzed procedure and the labeled proteins analysed by SDS-PAGE. A comparison ofdifferent procedures showed that the best resolution was achieved by autoradiography following the analysis of platelet samples on 7-12% gradient acrylamide slab gels. A typical analysis as performed on the platelets of patient W.B. is illustrated in Fig. 4 . Identification ofthe labeled bands was aided (a) by correlating the peaks of radioactivity with the individual PAS-stained GP as located on slab or rod gels, (b) by the analysis of 1251-labeled platelets of a patient with Glanzmann's thrombasthenia, whose platelets were specifically deficient in IIb and IlIa (31) , and (c) by direct comparison with the profiles given by Phillips and Poh Agin (22) . Analysis of reduced B-S platelet samples showed zones of radioactivity apparently normally associated with JIb and IIIa, the surface GP maximally labeled with 125I by the lactoperoxidase-catalyzed procedure. However, the close migration of Ib, Ia, and IIa prevented a precise evaluation of their '251-labeling intensities. In contrast, analysis of nonreduced samples, which more clearly separated Ib from the other major membrane GP (compare also Figs. 1 and 2) , showed a specific abnormality in the Ib position. shown. An absence of '25I-labeling in the Ib position is the striking feature of the autoradiograph of the B-S platelet gel and confirms the finding illustrated for the platelets of the patient (W.B.) in Fig. 4 Analysis of neuraminidase-treated platelets. Normal human platelet suspensions were incubated with neuraminidase under conditions which gave rise to the maximal release of surface sialic acid residues. The surface proteins of the desialated platelets, which had lost -50% of their total platelet sialic acid content, were then labeled with 125I by the lactoperoxidase-catalyzed procedure. Fig. 6 shows a PAS-profile typical of those obtained for neuraminidase-treated platelets following SDS-PAGE. A significant decrease in the PAS-staining capacity of Ib was observed, however, the GP was still a major contributor to the PAS-profile. Only minor mriodifications in the PAS-staining capacity labeled B-S platelet (PL) surface proteins. Washed suspensions of normal human platelets and those isolated from the patient (N.V.) were labeled with 125I as described in the legend to Fig. 4 . The platelets were dissolved with SDS in the presence of N-ethylmaleimide and samples (100 ,ug protein) subjected to first dimension electrophoresis using 7% acrylamide rod gels as described in the legend to Fig. 2 . After electrophoresis, the unstained gel were incubated in the presence of 5% vol/vol 2-mercaptoethanol and a second dimension electrophoresis of the now reduced proteins performed on 7-12% gradient acrylamide slab gels. A single sample of reduced 1251-labeled proteins (100 1Lg) of the sample being analysed was also applied to the right hand side of the slab gel. Protein-stained gels were dried onto filter paper and the _251-labeled proteins detected by autoradiography. Two weakly labeled low molecular weight polypeptides are marked (+-) in the lower part ofthe gel, these correspond to the ,p-subunits of Ic and Ilb respectively (22) . mol wt x 10-3 FIGURE 6 GP profile of neuraminidase-treated normal human platelets. Washed platelet suspensions were incubated for 15 min at 37°C in the presence or absence of neuraminidase (25 U neuraminidase/109 platelets). Samples of the control and neuraminidase-treated platelets were dissolved by SDS and analyzed without reduction on 7% acrylamide rod gels as described in the legend to Fig. 2 . GP were detected by the PAS-reaction, typical densitometric profiles are shown.
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A. T. Nurden, D. Dupuis, T. J. Kunicki, and J. P. Caen ofthe other membrane GP were detected. The residual Ib exhibited a slightly slower rate of migration during electrophoresis whereas that of IIb was increased. The altered migration of lb suggested that the observed peak represented desialated, or partially desialated, Ib rather than a GP fraction inaccessible to the action of the neuraminidase. Analysis of the 125I-labeled proteins by autoradiography clearly showed an 125I-labeled band in the GP Ib region of the gel although, as expected from the PASstaining, the band had a slightly slower migration (Fig.  7) . The identity of this band as Ib was confirmed using the nonreduced/reduced two dimensional SDS-PAGE system (data not shown). Apart from mobility changes, remarkably little alteration was observed in the distribution of 125I among the surface proteins of the desialated normal platelets. The protein profiles of the neuraminidase-treated platelets also showed no modifications, except for the altered rates of migration of lb and IIb now more clearly apparent owing to the greater sharpness of the protein-stained bands.
DISCUSSION
Despite the fact that a number of investigators have reported studies on the GP and polypeptide composition of B-S platelets (3, 11, 13-16, 21, 30, 34-36) , the conflicting data reported in the literature has made it difficult to precisely interpret the nature of the molecular lesion(s) of these functionally defective platelets. Our current work has been designed to clarify the nature of the structural abnormalities of B-S platelets.
Characterization of normal human platelet GP. In view of the difficulty in isolating well characterized membrane fractions from the platelets of patients with moderate to severe thrombocytopenia (each of the patients studied had a low circulating platelet count, Table I ) our investigation has been restricted to the analysis ofunfractionated washed platelet suspensions. Preliminary studies compared the GP resolution obtained using SDS-PAGE procedures incorporating a continuous SDS-phosphate buffer systerm similar to that used for platelet GP analysis by George et al. (37) , with procedures incorporating the discontinuous SDSTris glycine buffer system as employed by Phillips and Poh Agin (22) . Emphasis was placed on obtaining PAS profiles that allowed the quantitative evaluation of the major PAS-bands by densitometric scanning. The best resolution of the major PAS-staining GP was achieved using the discontinuous buffer system, reduced samples, and 6% acrylamide separating gels. In comparison with the GP profiles of reduced, whole platelets given by George et al. (37) Fig. 1 is the a subunit of Ib. The labeled Ib in the GP profile of nonreduced, normal platelets in Fig. 2 dimension SDS-PAGE procedure giving four major PAS-stained bands. In our studies using reduced control platelet samples an additional PAS-peak (band 4) was separated as a shoulder to the trailing edge of lb. This band was a marked feature of the reduced B-S platelet profiles. Only using nonreduced samples were we able to clearly resolve Ib from other membrane GP during single dimension SDS-PAGE. 125I-Labeling ofB-S platelet surface proteins. Jenkins et al. (14) and Hagen and Solum (34) both studied the surface proteins of B-S platelets using lactoperoxidase-catalyzed iodination and reported differing results. Jenkins et al. (14) found a highly abnormal profile of 125I-labeled proteins following SDS-PAGE, including the presence of numerous labeled low molecular weight polypeptides. In contrast, Hagen and Solum (34) described a normal 125I-labeling profile. Our results were consistent for the platelets of the three patients studied using this procedure; autoradiography following single and two-dimensional SDS-PAGE showed an absence of labeling in the Ib position. The other major 1251-labeled surface GP as detailed by Phillips and Poh Agin (22) were all normally detected. We located none of the changes previously described for B-S platelets by Jenkins et al. (14) .
In their studies Hagen and Solum (34) detected 125I-labeled polypeptides by slicing PAS-stained rod gels and measured the radioactivity in the slices using a gamma counter. We followed the same procedure initially but noted that accurate evaluation of lb was difficult owing to the small percentage of the total radioactivity located in the GP I region. Subsequently, we performed autoradiography after the separation of the labeled proteins on gradient slab gels. Exposure times ofup to 2 wk amplified the detection ofthe less-strongly labeled surface proteins. Furthermore, in view of the increased protein content of the B-S platelets (Table I) and their increased size (1, 6) , at least under the conditions of this study (38) , we decreased the concentration of B-S platelets during the lactoperoxidase-catalyzed iodination (see Methods). With these procedures, a clear absence of radioactivity in the Ib position was observed either after the analysis of 125I-labeled B-S platelets by the two-dimensional SDS-PAGE system or after the analysis of nonreduced samples on single dimension gradient acrylamide gels.
Relationship between Ib and glycocalicin. Solum and his co-workers (17, 39) have provided immunochemical evidence that lb is the membrane GP precursor of glycocalicin, a large (148,000 mol wt) glycopolypeptide composed of -60% by weight carbohydrate, that is solubilized from the platelet surface during platelet homogenization (40) . Our present results indirectly support this finding in that Ib was the only major PAS-staining GP to show a severe reduction in staining on analysis of B-S platelets, which have been shown in several studies to lack glycocalicin (15, 16, 21, 35) . George et al. (37) have expressed a similar view following the analysis of normal platelets before and after glycocalicin loss. In contrast, Nachman et al. (41) have claimed that lb and glycocalicin give different peptide maps following trypsin digestion and are different GP although absolute proof for the identification of Ib was not given.
Examination of neuraminidase-treated control platelets. In confirmation of the original report of Grottum and Solum (12) the platelets of the two B-S patients examined showed a decreased sialic acid content. However, despite the removal of -50% ofthe total sialic acid content of normal human platelets by neuraminidase treatment before 125I-labeling little change was induced in the pattern of the '25I-labeled GP as observed after SDS-PAGE. A clear band or spot in the Ib position remained on the autoradiographs. McGregor et al. (36) have suggested that there is either a severe reduction or an altered glycosylation of GP Ia and lb in B-S platelets. Our results point to the presence of Ia on the B-S platelet surface as this GP was apparently normally labeled with 125I during lactoperoxidasecatalyzed iodination. In contrast, any structural defects in Ib must be severe as we were unable to locate it by PAS staining, 1251-labeling, or, in previous studies, by crossed immunoelectrophoresis (15) . The presence ofa molecular deficiency of Ib in B-S platelets must be considered. Further studies are now being performed to examine the state ofglycosylation of GP Ia in the platelets of our patients, meanwhile its presence in their platelets has been recently confirmed by crossed immunoelectrophoresis.2
In agreement with McGregor et al. (42) we observed that GP Ib of normal human platelets migrated with an increased apparent molecular weight after neuraminidase treatment (see Figs. 6 and 7) . This slower rate of migration is probably due to the normal contribution of the anionic charge of sialic acid to the migration of lb during SDS-PAGE.
Possible origin of the B-S platelet defect. Our results emphasize that B-S platelets contain a specific and characteristic membrane lesion. We have obtained no evidence for the large scale changes in polypeptide composition as attributed to B-S platelets by Jenkins et al. (14) . Furthermore, we failed to detect signs of the presence of widespread endogenous protease activity in B-S platelets as proposed by Shulman and Karpatkin (16) . The possible presence of exogenous protease activity either in the bone marrow or plasma was also considered. If this was present then presumably the protease would be free to interact with the surface of other blood cells. Analysis of membranes isolated from erythrocytes of each patient, however, revealed no signs of GP degradation (unpublished results). If protease activity is the cause of the B-S platelet surface lesion then the protease must have a narrow specificity and a particular affinity for platelet GP lb.
The alternative hypothesis, therefore, is that a direct genetic defect at a stage in the synthesis of lb may be the cause of the B-S platelet membrane lesion. Studies on the megakaryocytes of B-S patients may be required to locate the origin of the abnormality. Meanwhile we emphasize that the B-S syndrome is a distinct congenital platelet disorder characterized by a distinctive membrane GP abnormality.
